Conditions: Hypertension
Keywords: Children pediatrics High Blood Pressure Hypertension Valsartan
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 66
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy, safety and tolerability of long-term use (up to 18 weeks) of valsartan in children 6 months to 5 years old with hypertension.

Detailed description:

Arms:
arm 1: Extemporaneous oral suspension prepared from valsartan tablets was administered to participants once daily. The starting dose of valsartan was 1 mg/kg, escalated to 2 mg/kg or 4 mg/kg based on mean sitting systolic blood pressure (MSSBP) control after 2 weeks up to 18 weeks.

Interventions: intervention 1: Valsartan
Intervention descriptions: intervention 1: Extemporaneous suspension of valsartan, orally.

Protocol document: